Manglio Rizzo

5PUBLICATIONS
27CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 13, 2025
4-Methylumbelliferone Modulates CAIX to Mitigate Hypoxia-Driven Dysregulation and Enhance PD-1 Immunotherapy in Lung Cancer.

Mariel Fusco, Carlos Rafael Picón, Marco Aurelio Diaz

|Oct 03, 2025
Real-World Outcomes in Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer in Argentina: A Multicenter Retrospective Study (GAOT-ALK001).

Luis Basbus, Maite Queral, Delfina Peralta Tanco

|Oct 06, 2023
Optimal Therapeutic Strategy for PD-L1 Negative Metastatic Non-Small Cell Lung Cancer: A Decision-Making Guide Based on Clinicopathological and Molecular Features.

Mariana Malvicini, Maysa Silveira Vilbert, José N Minatta

|Mar 14, 2021
Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting.

Manglio Miguel Rizzo, María Virginia Bluthgen, Gonzalo Recondo

|Aug 23, 2014
Human umbilical cord perivascular cells exhibited enhanced migration capacity towards hepatocellular carcinoma in comparison with bone marrow mesenchymal stromal cells: a role for autocrine motility factor receptor.

Juan Bayo, Esteban Fiore, Jorge B Aquino

Pageof 1

Frequent Collaborators

2 joint publications

Juan Bayo

1 joint publications

Mariel Fusco

1 joint publications

Carlos Rafael Picón

1 joint publications

Marco Aurelio Diaz